All In MedTech

FDA Clearance Tracker · K201219

Biocore9 Femoral Head Resurfacing Component

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jan 19, 2021 (this decision)Source: openFDAMethods & limitations

510(k)

The decision

FDA number
K201219
Device name
Biocore9 Femoral Head Resurfacing Component
Applicant
Biocore9, LLC
Applicant location
Whippany, NJ
Received
May 6, 2020
Decided
Jan 19, 2021
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 888.3400

Every decision under product code KXA

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code KXA. The earliest in FDA's data is K761324, decided Jan 5, 1977.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Biocore9, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.